Beta
Back to UNH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-flow-chart

UNH Cash Flow

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, UnitedHealth Group's (UNH) Operating Cash Flow reached $8.91B USD, reflecting a robust recovery from the low of $1.11B USD in Q4'25, while Free Cash Flow surged to $8.15B USD, up significantly from $0.16B USD in the prior quarter, indicating improved liquidity and capital efficiency at the latest point. Over the period from Q2'23 to Q1'26, Operating Cash Flow exhibited high volatility, peaking at $13.95B USD in Q3'24 before dipping to a negative -$5.19B USD in Q4'23, with an overall upward trend in recent quarters driven by seasonal strengths in Q3 periods; Free Cash Flow followed a similar pattern, achieving a high of $12.95B USD in Q3'24 but showing sharper declines during capital-intensive phases like Q4'23 (-$6.15B USD), underscoring UNH's cyclical cash generation tied to operational cycles and investments. This analysis highlights UNH's resilience in cash flows despite fluctuations, with both metrics demonstrating positive momentum into 2026, beneficial for financial analysts assessing sustainability.